Silverarc Capital Management »

SPDR S&P Biotech shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $22M 300k 73.02
2022-06-30 $16M 208k 74.27
2022-03-31 $27M 300k 89.88
2021-12-31 $22M 200k 111.96
2021-06-30 $13M 94k 135.40

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Susquehanna International
Citigroup
Citadel Advisors
Jpmorgan Chase & Co
Millennium Management
UBS Group
Bank of America Corporation
venBio Select Advisor
Bnp Paribas Arbitrage, Snc
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Wells Fargo & Company
Barclays

View all funds holding SPDR S&P Biotech